Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

This protocol presents choroid sprouting assay, an ex vivo model of microvascular proliferation. This assay can be used to assess pathways involved in proliferating choroidal micro vessels and assess drug treatments using wild type and genetically modified mouse tissue.

Streszczenie

Pathological choroidal angiogenesis, a salient feature of age-related macular degeneration, leads to vision impairment and blindness. Endothelial cell (EC) proliferation assays using human retinal microvascular endothelial cells (HRMECs) or isolated primary retinal ECs are widely used in vitro models to study retinal angiogenesis. However, isolating pure murine retinal endothelial cells is technically challenging and retinal ECs may have different proliferation responses than choroidal endothelial cells and different cell/cell interactions. A highly reproducible ex vivo choroidal sprouting assay as a model of choroidal microvascular proliferation was developed. This model includes the interaction between choroid vasculature (EC, macrophages, pericytes) and retinal pigment epithelium (RPE). Mouse RPE/choroid/scleral explants are isolated and incubated in growth-factor-reduced basal membrane extract (BME) (day 0). Medium is changed every other day and choroid sprouting is quantified at day 6. The images of individual choroid explant are taken with an inverted phase microscope and the sprouting area is quantified using a semi-automated macro plug-in to the ImageJ software developed in this lab. This reproducible ex vivo choroidal sprouting assay can be used to assess compounds for potential treatment and for microvascular disease research to assess pathways involved in choroidal micro vessel proliferation using wild type and genetically modified mouse tissue.

Wprowadzenie

Choroidal angiogenesis dysregulation is associated with neovascular age-related macular degeneration (AMD)1. The choroid is a microvascular bed present underneath the retinal pigment epithelium (RPE). It has been shown that reduced blood flow in the choroid is associated with progression of AMD2. The intricate relationship between vascular endothelium, RPE, macrophages, pericytes and other cells is responsible for the homeostasis of the tissue3,4,5. Therefore, a reproducible assay modeling choroidal microenvironment is critical for the study of neovascular AMD.

Ex vivo angiogenesis assays and in vitro endothelial cell cultures can complement studies of microvascular behavior in vivo, for testing new drugs and for studies of pathogenesis. Endothelial cells such as human retinal microvascular endothelial cells (HRMECs), Human Umbilical Vein Endothelial Cells (HUVEC), isolated primary animal brain or retinal ECs are often used in in vitro studies for ocular angiogenesis research6,7,8. HRMECs in particular have been widely used as a model of in vitro choroidal neovascularization (CNV)9 by assessing endothelial proliferation, migration, tubular formation, and vascular leakage to evaluate interventions6,10. However, ECs in culture are limited as a model of CNV because of the lack of interactions with other cell types found in the choroid and because most EC used in these assays do not originate from choroid. Mouse choroidal ECs are difficult to isolate and maintain in culture.

The aortic ring assay is widely used as a model of macro vascular proliferation. Vascular sprouts from aortic explants include ECs, pericytes and macrophages11. The aortic ring assay models large vessel angiogenesis well12,13,14. However, it has limitations as a model of choroidal neovascularization as aortic rings are a macrovascular tissue lacking the characteristic choroidal microvascular environment, and sprouts from large vessels may differ from sprouts from capillary networks involved in microvascular pathology. Recently a group published an ex-vivo retinal assay15,16. Although, it is suitable for retinal neovascular disease, it is not as appropriate for choroidal neovascularization as seen in AMD.

The choroidal sprouting assay using mouse RPE, choroid, and scleral explanted tissue was developed to better model CNV. The tissue can easily be isolated from mouse (or other species) eyes17. This assay allows reproducible evaluation of pro- and anti-angiogenic potential of pharmacologic compounds and evaluation of the role of specific pathways in choroidal neovascularization using tissue from genetically modified mice and controls18. This choroidal sprouting assay has been referenced in many subsequent publications9,10,18,19,20. Here, the method involved in the use of this assay are demonstrated.

Protokół

All animal experiments described were approved by the Institutional Animal Care and Use Committee at Boston Children’s Hospital (ARCH protocol number 19-04-3913R).

1. Preparation

  1. Add 5 mL of Penicillin/Streptomycin (10000 U/mL) and 5 mL and 10 mL of commercially available supplements to 500 mL of complete classic medium with serum. Aliquot 50 mL of the medium initially.
    NOTE: Do not return any medium back to the stock to avoid contamination.
  2. Put an aliquot of complete classic medium on ice.
  3. Use 70% ethanol to clean the dissecting microscope, forceps, and scissors.
  4. Prepare two cell culture dishes (10 cm), one on the dissection microscope, one on ice; put 10 mL of complete classic medium in each dish.

2. Experimental steps (Figure 1)

  1. Sacrifice C57BL/6J mice around postnatal (P) 20 using 75-100 mg/kg ketamine and 7.5 -10 mg/kg xylazine injected intraperitoneally. Keep the eyes in complete classic medium on ice before dissection.
  2. Remove the connective tissue (muscle and fatty tissue) and optic nerve on the eye.
  3. Use a micro-scissor to circumferentially cut 0.5 mm posterior to the corneal limbus. Remove the cornea/iris complex, vitreous and the lens.
  4. Make a 1 mm incision perpendicular to the cut edge towards the optic nerve and cut a circumferential band of 1 mm width. Separate the central and peripheral regions of the complex. Use forceps to peel off the retina from RPE/choroid/sclera complex. 
  5. Keep the peripheral choroid band in complete classic medium on ice; isolate the other eye and repeat the process to cut a second band.
  6. Cut the circular band into 6 ~equal square pieces (~1 mm x 1 mm).
    NOTE: Never touch any edge.
  7. Thaw the basal membrane extract (BME) per manufacture’s instruction. Add 30 µL/well of BME into the center of each well of a 24 well tissue culture plate. Make sure the droplet of BME forms a convex dome at the bottom of the plate without touching the edges.
    NOTE: Thaw the BME overnight in a refrigerator. BME should be on the ice any time after thawing.
  8. Place the tissue in the middle of the BME.
    NOTE: Do not flatten the choroid explant; generally, let the tissue expand within the BME. The orientation of the tissue (scleral side up or down) does not impact the experimental outcome.
  9. Incubate the plate at 37 °C for 10 min to let the gel solidify.
  10. Add 500 µL of the complete classic medium/well.
  11. Change the classic medium every other day (500 µL). Choroid sprouting can be observed after 3 days with a microscope.
    NOTE: For growth factor treatment, starve the tissue for 4 h. Dilute a trial compound in growth factor-reduced medium (1:200 boost instead of 1:50).

3. SWIFT-Choroid computerized quantification method17 (Figure 2)

NOTE: A computerized method to measure the area covered by growing vessels was used. A macro plugin to ImageJ software is needed prior to quantification (see Supplemental Information for further detail).

  1. Open the choroid sprouting image with ImageJ and check “Image | Type| 8-bit” with gray scale.
  2. Go to “Image | Adjust | Brightness/Contrast (Ctrl/shift/C)” and optimize the contrast.
  3. Use the magic wand function to outline and remove from the image the choroid tissue which are present in the center of the sprouts (using shortcut key “F1”) (Figure 2A,B).
    NOTE: Set the tolerance rate of the magic wand to 20-30%.
  4. Remove the background of the image with the free selection tools (Figure 2C). Go to “Image | Adjust | Threshold (Ctrl/shift/T)”. Use the threshold function to define the microvascular sprouts against the background and periphery (Figure 2D).
  5. Click “F2” and a summary will appear. Save an image of the selected area by clicking “Save”. Save in the same folder as the original image for future reference.
  6. After a group of samples is measured, copy the recorded for data analysis.
    NOTE: It is also possible to measure the area (µm²) by “Analyze | Set Scale” using images with scale bars.

Wyniki

Comparison of choroid sprouting growth per day

We dissected the choroid with sclera, embedded in BME and cultured them for 6 days (Figure 1). The choroid sprouting in C57BL/6J mice from day 3 to day 6 were examined with a microscope and quantified with SWIFT-Choroid a semi-automated quantification method in ImageJ. In a representative case, the choroidal sprouting area (the vessels extending from the explant, excluding the explant itself) was 0.38...

Dyskusje

The choroidal sprouting assay aids research in neovascular AMD9,10,18,19,20. Choroid explants can be isolated from mice as well as rats and humans17,21. The choroid explant includes ECs, macrophages, and pericytes17. In this assay the interaction between choroidal ECs and adjace...

Ujawnienia

The authors have no financial disclosures. The computerized method is available free of charge to academic institutions through the authors.

Podziękowania

The work was supported by Grants from the Manpei Suzuki Diabetic Foundation (YT), Boston Children's Hospital OFD/BTREC/CTREC Faculty Career Development Grant, Boston Children's Hospital Ophthalmology Foundation, BCH Pilot Award, BCH Manton Center Fellowship, and Little Giraffe Foundation (ZF), The German Research Foundation (DFG; to BC [CA1940/1-1]), NIH R24EY024868, EY017017, R01EY01717-13S1, EY030904-01, BCH IDDRC (1U54HD090255), Massachusetts Lions Eye Foundation (LEHS).

Materiały

NameCompanyCatalog NumberComments
AnaSed (Xylazine)AKORN59339-110-20
Basal membrane extract (BME) MatrigelBD Biosciences354230
Cell culture dishNEST70400110cm
Complete classic medium with serum and CultureBoostCell systems4Z0-500
Ethyl alcohol 200 ProofPharmco111000200use for 70%
KimwipesKimberly-Clark06-666
MicroscopeZEISSAxio Observer Z1
Penicillin/StreptomycinGIBCO1514010000 U/mL
Tissue culture plate (24-well)Olympus25-107
VetaKet CIII (Ketamine)AKORN59399-114-10

Odniesienia

  1. Zarbin, M. A. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol. 122 (4), 598-614 (2004).
  2. Pemp, B., Schmetterer, L. Ocular blood flow in diabetes and age-related macular degeneration. Canadian Journal of Ophthalmology. 43 (3), 295-301 (2008).
  3. Murakami, Y., Ishikawa, K., Nakao, S., Sonoda, K. H. Innate immune response in retinal homeostasis and inflammatory disorders. Progress in Retinal and Eye Research. 74, 100778 (2020).
  4. Fu, Z., et al. Dyslipidemia in retinal metabolic disorders. EMBO Molecular Medicine. 11 (10), 10473 (2019).
  5. Daruich, A., et al. Mechanisms of macular edema: Beyond the surface. Progress in Retinal and Eye Research. 63, 20-68 (2018).
  6. Tomita, Y., et al. Long-Acting FGF21 Inhibits Retinal Vascular Leakage in In Vivo and In Vitro Models. International Journal of Molecular Sciences. 21 (4), 21041188 (2020).
  7. Maisto, R., et al. ARPE-19-derived VEGF-containing exosomes promote neovascularization in HUVEC: the role of the melanocortin receptor 5. Cell Cycle. 18 (4), 413-424 (2019).
  8. Mazzoni, J., et al. The Wnt Inhibitor Apcdd1 Coordinates Vascular Remodeling and Barrier Maturation of Retinal Blood Vessels. Neuron. 96 (5), 1055-1069 (2017).
  9. Fu, Z., et al. Adiponectin Mediates Dietary Omega-3 Long-Chain Polyunsaturated Fatty Acid Protection Against Choroidal Neovascularization in Mice. Investigative Ophthalmology and Visual Sciences. 58 (10), 3862-3870 (2017).
  10. Gong, Y., et al. Cytochrome P450 Oxidase 2C Inhibition Adds to omega-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization. Arteriosclerosis, Thrombosis and Vascular Biology. 36 (9), 1919-1927 (2016).
  11. Nicosia, R. F., Zorzi, P., Ligresti, G., Morishita, A., Aplin, A. C. Paracrine regulation of angiogenesis by different cell types in the aorta ring model. International Journal of Developmental Biology. 55 (4-5), 447-453 (2011).
  12. Bellacen, K., Lewis, E. C. Aortic ring assay. Journal of Visulaized Experiments. (33), e1564 (2009).
  13. Masson, V. V., et al. Mouse Aortic Ring Assay: A New Approach of the Molecular Genetics of Angiogenesis. Biological Procedures Online. 4, 24-31 (2002).
  14. Katakia, Y. T., et al. Ex vivo model for studying endothelial tip cells: Revisiting the classical aortic-ring assay. Microvascular Research. 128, 103939 (2020).
  15. Rezzola, S., et al. In vitro and ex vivo retina angiogenesis assays. Angiogenesis. 17 (3), 429-442 (2014).
  16. Rezzola, S., et al. A novel ex vivo murine retina angiogenesis (EMRA) assay. Experimental Eye Research. 112, 51-56 (2013).
  17. Shao, Z., et al. Choroid sprouting assay: an ex vivo model of microvascular angiogenesis. PLoS One. 8 (7), 69552 (2013).
  18. Tomita, Y., et al. Free fatty acid receptor 4 activation protects against choroidal neovascularization in mice. Angiogenesis. 23, 385-394 (2020).
  19. Li, J., et al. Endothelial TWIST1 promotes pathological ocular angiogenesis. Investigative Ophthalmology and Vision Science. 55 (12), 8267-8277 (2014).
  20. Liu, C. H., et al. Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization. Proceedings of the National Academy of Science U. S. A. 112 (39), 12163-12168 (2015).
  21. Zhou, Q., et al. LncEGFL7OS regulates human angiogenesis by interacting with MAX at the EGFL7/miR-126 locus. Elife. 8, 40470 (2019).
  22. Kobayashi, S., Fukuta, M., Kontani, H., Yanagita, S., Kimura, I. A quantitative assay for angiogenesis of cultured choroidal tissues in streptozotocin-diabetic Wistar and spontaneously diabetic GK rats. Japanese Journal of Pharmacology. 78 (4), 471-478 (1998).
  23. Kobayashi, S., et al. Inhibitory effects of tetrandrine and related synthetic compounds on angiogenesis in streptozotocin-diabetic rodents. Biological and Pharmaceutical Bulletin. 22 (4), 360-365 (1999).
  24. Kobayashi, S., Shinohara, H., Tsuneki, H., Nagai, R., Horiuchi, S. N(epsilon)-(carboxymethyl)lysine proliferated CD34(+) cells from rat choroidal explant in culture. Biological and Pharmaceutical Bulletin. 27 (9), 1382-1387 (2004).
  25. Kobayashi, S., et al. Overproduction of N(epsilon)-(carboxymethyl)lysine-induced neovascularization in cultured choroidal explant of streptozotocin-diabetic rat. Biological and Pharmaceutical Bulletin. 27 (10), 1565-1571 (2004).
  26. Bergers, G., Song, S. The role of pericytes in blood-vessel formation and maintenance. Neuro-Oncology. 7 (4), 452-464 (2005).
  27. Browning, A. C., Stewart, E. A., Amoaku, W. M. Reply to: Phenotypic plasticity of human umbilical vein endothelial cells. British Journal of Ophthalmology. 96 (9), 1275-1276 (2012).

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Ex Vivo Choroid Sprouting AssayOcular Microvascular AngiogenesisChoroidal AngiogenesisAge related Macular DegenerationNeovascular AMDMicrovascular BehaviorWild Type Mouse TissueGenetically Modified Mouse TissueBasal Membrane ExtractComplete Classic MediumTissue Culture PlatesChoroid ExplantRetinal Pigment Epithelium RPEBME Gel SolidificationChoroid Sprouting Observation

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone